Thursday, 26 August 2021 (YJC)_ A senior Iranian health official announced that the country is going to produce 3 new coronavirus vaccines next year.
Member of the Scientific Committee of Coronavirus Combat and Prevention Mostafa Qaneyee announced that the country is going to produce 3 new coronavirus vaccines next year.
“Thus far, a total of 9 domestic firms have entered the field of producing coronavirus vaccines, and right now two vaccines are on the edge of receiving clinical licenses,” he said.
Qaneyee went on to add that “The vaccine is using the killed or inactivated version of the virus” and announced that “The company that produces this kind of vaccine will enter the third phase of the clinical trial by the end of the year.”
“Another company that has worked on the mRNA-based coronavirus vaccine is going to to enter the clinical phase after receiving a license and right now the company has gone through a preclinical phase," he noted.
He finally announced that “Another vaccine due to be produced next year in Iran.”
Iran has already produced several coronavirus vaccines, a number of which have reached even the third phase of human trial.
Previously, on Sunday, Commander of the Islamic Revolution Guards Corps (IRGC) Major General Hossein Salami said that the home-made anti-coronavirus vaccine is ready to enter the second stage of clinical trial while he was visiting the inauguration of a 64-bed hospital for coronavirus patients in Kerman in Southeastern Iran.
“Noora vaccine is passing the necessary phases and will reach final stage in next few months,” he said while noting that “Our domestic vaccine, Noora, was successful in its first phase of clinical trial; now effective steps have been taken for entering the second phase of clinical trial.”
During a ceremony in June in the presence of General Salami, Iran’s Health Minister Saeed Namaki and other Iranian health officials the recombinant Noora vaccine, produced by Baqiyatallah University of Medical Sciences, was put on display.
Baqiyatallah University of Medical Sciences in Tehran works under the supervision of the IRGC. Noora vaccine reached the stage of the clinical trial after 16 months of research work by Iranian scientists.